{"id":"W3043733200","doi":"10.1080/09546634.2020.1793891","title":"Cost per responder analysis of guselkumab versus targeted therapies in the treatment of moderate to severe plaque psoriasis in Germany","year":2020,"lang":"en","type":"article","venue":"Journal of Dermatological Treatment","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":15,"is_retracted":false,"has_abstract":true,"ca_institutions":"EVERSANA (Canada)","funders":"","keywords":"Medicine; Secukinumab; Psoriasis Area and Severity Index; Psoriasis; Adalimumab; Dermatology; Adverse effect; Internal medicine; Psoriatic arthritis; Rheumatoid arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01113128,0.001082088,0.002876426,0.001501523,0.0001850519,0.001744738,0.001384981,0.001157437,0.002389228],"category_scores_gemma":[0.01068184,0.0007912077,0.01119541,0.001409672,0.0003711414,0.001072935,0.000811536,0.001292531,0.0001613495],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.006654306,"about_ca_system_score_gemma":0.002354365,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.01796832,"about_ca_topic_score_gemma":0.009738739,"domain_scores_codex":[0.994696,0.004273373,0.0001641403,0.0003116386,0.0003038024,0.000251176],"domain_scores_gemma":[0.9939532,0.004563539,0.0009734096,0.000201894,0.0001581526,0.0001497949],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"simulation_or_modeling","study_design_gemma":"observational","study_design_scores_codex":[0.07694855,0.001534172,0.05445439,0.009573868,0.1115824,0.0006292078,0.0001551493,0.6533835,0.00115982,0.008705483,0.005348013,0.07652545],"study_design_scores_gemma":[0.02667403,0.02201252,0.1686339,0.003558135,0.243883,0.0008785894,0.0005219887,0.5086824,0.003071064,0.0112616,0.01043421,0.0003886211],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9097306,0.0702571,0.006485799,0.002600972,0.0002617837,0.0006453456,0.006885446,0.0001231389,0.003009845],"genre_scores_gemma":[0.9925427,0.004093889,0.00116376,0.0003011134,0.00004031939,0.000183881,0.001139869,0.00001648313,0.0005179879],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01796832,"threshold_uncertainty_score":0.05886859,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07257574718631102,"score_gpt":0.3027416133475172,"score_spread":0.2301658661612062,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}